国产乱人视频免费观看网站,九九精品视频在线观看,九九久re8在线精品视频,日韩久久精品五月综合

<menu id="zjelp"></menu>

    <th id="zjelp"><tbody id="zjelp"><form id="zjelp"></form></tbody></th>
    <small id="zjelp"><menuitem id="zjelp"></menuitem></small>
  • <small id="zjelp"></small>

    <address id="zjelp"></address>
    <address id="zjelp"></address>
    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf

    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf

    ID:50643582

    大?。?80.60 KB

    頁(yè)數(shù):7頁(yè)

    時(shí)間:2020-03-16

    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第1頁(yè)
    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第2頁(yè)
    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第3頁(yè)
    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第4頁(yè)
    冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第5頁(yè)
    資源描述:

    《冠狀病毒Coronavirusl論文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。

    1、VIRALIMMUNOLOGYOriginalArticlesVolume26,Number2,2013aMaryAnnLiebert,Inc.Pp.126–132DOI:10.1089/vim.2012.0076ImmunogenicityandProtectionEf?cacyofMonomericandTrimericRecombinantSARSCoronavirusSpikeProteinSubunitVaccineCandidates1,22221JieLi,LauraUlitzky,EricaSilbe

    2、rstein,DeborahR.Taylor,andRaphaelViscidiAbstractSevereacuterespiratorysyndrome(SARS)isanewlyemerginginfectiousdisease,andaneffectivevaccineisnotavailable.Inthisstudy,wecomparedtheimmunogenicityandprotectionef?cacyofrecombinantproteinscorrespondingtodifferentdom

    3、ainsoftheSARS-coronavirusspikeprotein.TrimericrecombinantproteinswerecreatedbyfusingthefoldondomainderivedfromT4bacteriophagetothecarboxy-terminiofindividualdo-mainsofthespikeprotein.Whilethefull-lengthectodomain(S)ofthespikeprotein,thefull-lengthectodomainfuse

    4、dtofoldon(S-foldon),theS1domain(S1),S1-foldon,andtheS2domain(S2)antigensallelicitedcomparableantibodytitersasmeasuredbyELISA,S-foldoninducedasigni?cantlyhighertiterofneutralizingantibodyandS2proteindidnotelicitvirusneutralizingantibodies.Whentestedinamousevirus

    5、replicationmodel,allthemicevaccinatedwiththeS1,S1-foldon,S,orS-foldonwerecompletelyprotected.IntroductionsideredamaintargetforSARSvaccines(6).Inthepresentstudy,wecomparedthefull-lengthectodomainofSproteinSevereacuterespiratorysyndrome(SARS)-associatedanditsfrag

    6、ments(S1andS2domains)withrespecttoim-coronavirus(SARS-CoV)isanemerginginfectiouspath-munogenicityandprotectionagainstviralinfectioninmice.ogenofzoonoticorigin.AlthoughnonewcasesofSARShaveInitsnativestate,Sproteinisatrimer;however,whenitsbeenreportedsince2004,SA

    7、RShasthepotentialtore-emergeectodomainisexpressedasarecombinantproteinineu-fromananimalreservoirorthroughaccidentalorintentionalkaryoticsystems,theproteinexistspredominantlyinamo-release.Therefore,thedevelopmentofeffectivevaccinesisnomericform(7).Tomaketrimeric

    8、recombinantspikehighlydesirableforthepreventionandcontainmentoffutureproteins,weexploiteda27-aminoacidsequence,calledtheoutbreaksofSARS.foldondomain,whichwasidenti?edintheba

    當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

    此文檔下載收益歸作者所有

    當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
    溫馨提示:
    1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問題,請(qǐng)放心下載。
    2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
    3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
    4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。